Identification of the role of presenilins beyond Alzheimer's disease

Pharmacological Research

Volumn 50, Issue 4, 2004, Pages 411-418

  Thinakaran, Gopal ^a   Parent, Angèle T ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Alzheimer's disease; Mutation; Presenilin

Indexed keywords

BETA CATENIN; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; APOPTOSIS; CALCIUM HOMEOSTASIS; CELL ADHESION; CELL FUNCTION; DNA CLEAVAGE; GENE IDENTIFICATION; GENE MUTATION; GENETIC LINKAGE; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; SYNAPSE;

EID: 4043052896     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2003.12.026     Document Type: Article

References (105)

1. Takasugi N., Tomita T., Hayashi I., Tsuruoka M., Niimura M., Takahashi Y., et al. The role of presenilin cofactors in the γ-secretase complex. Nature. 422:2003;438-441
2. Kimberly W.T., LaVoie M.J., Ostaszewski B.L., Ye W., Wolfe M.S., Selkoe D.J. γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc. Natl. Acad. Sci. U.S.A. 100:2003;6382-6387
3. Kim SH, Ikeuchi T, Yu C, Sisodia SS. Regulated hyperaccumulation of presenilin-1 and the "γ-secretase" complex: evidence for differential intramembranous processing of transmembrane substrates. J Biol Chem 2003.
4. Thinakaran G., Borchelt D.R., Lee M.K., Slunt H.H., Spitzer L., Kim G., et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 17:1996;181-190
5. Thinakaran G., Harris C.L., Ratovitski T., Davenport F., Slunt H.H., Price D.L., et al. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J. Biol. Chem. 272:1997;28415-28422
6. Li Y.M., Xu M., Lai M.T., Huang Q., Castro J.L., DiMuzio-Mower J., et al. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1. Nature. 405:2000;689-694
7. Esler W.P., Kimberly W.T., Ostaszewski B.L., Diehl T.S., Moore C.L., Tsai J.Y., et al. Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1. Nat. Cell Biol. 2:2000;428-434
8. Edbauer D., Winkler E., Regula J.T., Pesold B., Steiner H., Haass C. Reconstitution of γ-secretase activity. Nat. Cell Biol. 5:2003;486-488
9. Leem J.Y., Vijayan S., Han P., Cai D., Machura M., Lopes K.O., et al. Presenilin 1 is required for maturation and cell surface accumulation of nicastrin. J. Biol. Chem. 277:2002;19236-19240
10. Li T., Ma G., Cai H., Price D.L., Wong P.C. Nicastrin is required for assembly of presenilin/γ-secretase complexes to mediate Notch signaling and for processing and trafficking of β-amyloid precursor protein in mammals. J. Neurosci. 23:2003;3272-3277
11. LaVoie MJ, Fraering PC, Ostaszewski BL, Ye W, Kimberly WT, Wolfe MS, et al. Assembly of the γ-secretase complex involves early formation of an intermediate sub-complex of Aph-1 and Nicastrin. J Biol Chem 2003.
12. Esler W.P., Kimberly W.T., Ostaszewski B.L., Ye W., Diehl T.S., Selkoe D.J. Activity-dependent isolation of the presenilin-γ-secretase complex reveals nicastrin and a γ substrate. Proc. Natl. Acad. Sci. U.S.A. 99:2002;2720-2725
13. Beher D., Fricker M., Nadin A., Clarke E.E., Wrigley J.D., Li Y.M., et al. In vitro characterization of the presenilin-dependent γ-secretase complex using a novel affinity ligand. Biochemistry. 42:2003;8133-8142
14. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:1996;864-870
15. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 391:1998;387-390
16. De Strooper B., Annaert W., Cupers P., Saftig P., Craessaerts K., Mumm J.S., et al. A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain. Nature. 398:1999;518-522
17. Struhl G., Greenwald I. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature. 398:1999;522-525
18. Mumm J.S., Schroeter E.H., Saxena M.T., Griesemer A., Tian X., Pan D.J., et al. A ligand-induced extracellular cleavage regulates γ-secretase-like proteolytic activation of Notch1. Mol. Cell. 5:2000;197-206
19. Struhl G., Adachi A. Requirements for presenilin-dependent cleavage of Notch and other transmembrane proteins. Mol. Cell. 6:2000;625-636
20. Ikeuchi T., Sisodia S.S. The Notch ligands, Delta1 Jagged2, are substrates for presenilin-dependent "γ-secretase" cleavage. J. Biol. Chem. 278:2003;7751-7754
21. LaVoie M.J., Selkoe D.J. The Notch ligands, Jagged and Delta, are sequentially processed by α-secretase and presenilin/γ-secretase and release signaling fragments. J. Biol. Chem. 278:2003;34427-34437
22. Lee H.J., Jung K.M., Huang Y.Z., Bennett L.B., Lee J.S., Mei L., et al. Presenilin-dependent γ-secretase-like intramembrane cleavage of ErbB4. J. Biol. Chem. 277:2002;6318-6323
23. Murakami D., Okamoto I., Nagano O., Kawano Y., Tomita T., Iwatsubo T., et al. Presenilin-dependent γ-secretase activity mediates the intramembranous cleavage of CD44. Oncogene. 22:2003;1511-1516
24. Selkoe D, Kopan R. Notch and presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 2003.
25. Taniguchi Y., Kim S.H., Sisodia S.S. Presenilin-dependent "γ-secretase" processing of deleted in colorectal cancer (DCC). J. Biol. Chem. 278:2003;30425-30428
26. May P., Reddy Y.K., Herz J. Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J. Biol. Chem. 277:2002;18736-18743
27. Ni C.Y., Murphy M.P., Golde T.E., Carpenter G. γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science. 294:2001;2179-2181
28. Jung KM, Tan S, Landman N, Petrova K, Murray S, Lewis R, et al. Regulated intramembrane proteolysis of the p75 neurotrophin receptor modulates its association with the TrkA receptor. J Biol Chem 2003.
29. Kanning K.C., Hudson M., Amieux P.S., Wiley J.C., Bothwell M., Schecterson L.C. Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability. J. Neurosci. 23:2003;5425-5436
30. Meyer E.L., Strutz N., Gahring L.C., Rogers S.W. Glutamate receptor subunit 3 is modified by site-specific limited proteolysis including cleavage by γ-secretase. J. Biol. Chem. 278:2003;23786-23796
31. Van Gassen G., Annaert W., Van Broeckhoven C. Binding partners of Alzheimer's disease proteins: are they physiologically relevant? Neurobiol. Dis. 7:2000;135-151
32. Passer B.J., Pellegrini L., Vito P., Ganjei J.K., D'Adamio L. Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-(XL). A potential role in modulating the threshold of cell death. J. Biol. Chem. 274:1999;24007-24013
33. Pigino G., Morfini G., Pelsman A., Mattson M.P., Brady S.T., Busciglio J. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J. Neurosci. 23:2003;4499-4508
34. Zhou J., Liyanage U., Medina M., Ho C., Simmons A.D., Lovett M., et al. Presenilin 1 interaction in the brain with a novel member of the Armadillo family. Neuroreport. 8:1997;2085-2090
35. Nishimura M., Yu G., Levesque G., Zhang D.M., Ruel L., Hen F., et al. Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin, a component of the presenilin protein complex. Nat. Med. 5:1999;164-169
36. Kang D.E., Soriano S., Frosch M.P., Collins T., Naruse S., Sisodia S.S., et al. Presenilin 1 facilitates the constitutive turnover of β-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the β-catenin-signaling pathway. J. Neurosci. 19:1999;4229-4237
37. Kang D.E., Soriano S., Xia X., Eberhart C.G., De Strooper B., Zheng H., et al. Presenilin couples the paired phosphorylation of β-catenin independent of axin: implications for β-catenin activation in tumorigenesis. Cell. 110:2002;751-762
38. Noll E., Medina M., Hartley D., Zhou J., Perrimon N., Kosik K.S. Presenilin affects arm/β-catenin localization and function in Drosophila. Dev. Biol. 227:2000;450-464
39. Xia X., Qian S., Soriano S., Wu Y., Fletcher A.M., Wang X.J., et al. Loss of presenilin 1 is associated with enhanced β-catenin signaling and skin tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 98:2001;10863-10868
40. Yuasa S., Nakajima M., Aizawa H., Sahara N., Koizumi K., Sakai T., et al. Impaired cell cycle control of neuronal precursor cells in the neocortical primordium of presenilin-1-deficient mice. J. Neurosci. Res. 70:2002;501-513
41. Janicki S.M., Monteiro M.J. Presenilin overexpression arrests cells in the G1 phase of the cell cycle. Arrest potentiated by the Alzheimer's disease PS2(N141I)mutant. Am. J. Pathol. 155:1999;135-144
42. Meredith J.E. Jr., Wang Q., Mitchell T.J., Olson R.E., Zaczek R., Stern A.M., et al. γ-Secretase activity is not involved in presenilin-mediated regulation of β-catenin. Biochem. Biophys. Res. Commun. 299:2002;744-750
43. Saura C.A., Tomita T., Soriano S., Takahashi M., Leem J.Y., Honda T., et al. The non-conserved hydrophilic loop domain of presenilin (PS) is neither required for PS endoproteolysis nor enhanced Aβ42 production mediated by familial Alzheimer's disease-linked PS variants. J. Biol. Chem. 275:2000;17136-17142
44. Xia X., Wang P., Sun X., Soriano S., Shum W.K., Yamaguchi H., et al. The aspartate-257 of presenilin 1 is indispensable for mouse development and production of β-amyloid peptides through β-catenin-independent mechanisms. Proc. Natl. Acad. Sci. U.S.A. 99:2002;8760-8765
45. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling: cell fate control and signal integration in development. Science. 284:1999;770-776
46. Sestan N., Artavanis-Tsakonas S., Rakic P. Contact-dependent inhibition of cortical neurite growth mediated by notch signaling. Science. 286:1999;741-746
47. Berezovska O., McLean P., Knowles R., Frosh M., Lu F.M., Lux S.E., et al. Notch1 inhibits neurite outgrowth in post-mitotic primary neurons. Neuroscience. 93:1999;433-439
48. Redmond L., Oh S.R., Hicks C., Weinmaster G., Ghosh A. Nuclear Notch1 signaling and the regulation of dendritic development. Nat. Neurosci. 3:2000;30-40
49. Berezovska O., Frosch M., McLean P., Knowles R., Koo E., Kang D., et al. The Alzheimer-related gene presenilin 1 facilitates notch 1 in primary mammalian neurons. Brain Res. Mol. Brain Res. 69:1999;273-280
50. Wittenburg N., Eimer S., Lakowski B., Rohrig S., Rudolph C., Baumeister R. Presenilin is required for proper morphology and function of neurons in C. elegans. Nature. 406:2000;306-309
51. Levy O.A., Lah J.J., Levey A.I. Notch signaling inhibits PC12 cell neurite outgrowth via RBP-J-dependent and -independent mechanisms. Dev. Neurosci. 24:2002;79-88
52. Franklin J.L., Berechid B.E., Cutting F.B., Presente A., Chambers C.B., Foltz D.R., et al. Autonomous and non-autonomous regulation of mammalian neurite development by Notch1 and Delta1. Curr. Biol. 9:1999;1448-1457
53. Figueroa D.J., Morris J.A., Ma L., Kandpal G., Hen E., Li Y.M., et al. Presenilin-dependent γ-secretase activity modulates neurite outgrowth. Neurobiol. Dis. 9:2002;49-60
54. Busciglio J., Hartmann H., Lorenzo A., Wong C., Baumann K., Sommer B., et al. Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease. J. Neurosci. 17:1997;5101-5107
55. Lah J.J., Heilman C.J., Nash N.R., Rees H.D., Yi H., Counts S.E., et al. Light and electron microscopic localization of presenilin-1 in primate brain. J. Neurosci. 17:1997;1971-1980
56. Beher D., Elle C., Underwood J., Davis J.B., Ward R., Karran E., et al. Proteolytic fragments of Alzheimer's disease-associated presenilin 1 are present in synaptic organelles and growth cone membranes of rat brain. J. Neurochem. 72:1999;1564-1573
57. Georgakopoulos A., Marambaud P., Efthimiopoulos S., Shioi J., Cui W., Li H.C., et al. Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol. Cell. 4:1999;893-902
58. Goda Y. Cadherins communicate structural plasticity of presynaptic and post-synaptic terminals. Neuron. 35:2002;1-3
59. Togashi H., Abe K., Mizoguchi A., Takaoka K., Chisaka O., Takeichi M. Cadherin regulates dendritic spine morphogenesis. Neuron. 35:2002;77-89
60. Murase S., Mosser E., Schuman E.M. Depolarization drives β-catenin into neuronal spines promoting changes in synaptic structure and function. Neuron. 35:2002;91-105
61. Marambaud P., Shioi J., Serban G., Georgakopoulos A., Sarner S., Nagy V., et al. A presenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21:2002;1948-1956
62. Kim D.Y., Ingano L.A., Kovacs D.M. Nectin-1α, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/γ-secretase-like cleavage. J. Biol. Chem. 277:2002;49976-49981
63. Annaert W.G., Esselens C., Baert V., Boeve C., Snellings G., Cupers P., et al. Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron. 32:2001;579-589
64. Lammich S., Okochi M., Takeda M., Kaether C., Capell A., Zimmer A.K., et al. Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Aβ-like peptide. J. Biol. Chem. 277:2002;44754-44759
65. Price D.L., Tanzi R.E., Borchelt D.R., Sisodia S.S. Alzheimer's disease: genetic studies and transgenic models. Annu. Rev. Genet. 32:1998;461-493
66. Seabrook G.R., Rosahl T.W. Transgenic animals relevant to Alzheimer's disease. Neuropharmacology. 38:1999;1-17
67. Parent A., Linden D.J., Sisodia S.S., Borchelt D.R. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1. Neurobiol. Dis. 6:1999;56-62
68. Barrow P.A., Empson R.M., Gladwell S.J., Anderson C.M., Killick R., Yu X., et al. Functional phenotype in transgenic mice expressing mutant human presenilin-1a. Neurobiol. Dis. 7:2000;119-126
69. Zaman S.H., Parent A., Laskey A., Lee M.K., Borchelt D.R., Sisodia S.S., et al. Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine. Neurobiol. Dis. 7:2000;54-63
70. Schneider I., Reverse D., Dewachter I., Ris L., Caluwaerts N., Kuiperi C., et al. Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation. J. Biol. Chem. 276:2001;11539-11544
71. Pybus R., Barnard E., Estibeiro P., Mullins J., MacLeod N. Enhanced long-term potentiation in the hippocampus of rats expressing mutant presenillin-1 is age related. Neurobiol. Dis. 12:2003;212-224
72. Morton R.A., Kuenzi F.M., Fitzjohn S.M., Rosahl T.W., Smith D., Zheng H., et al. Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenilin-1. Neurosci. Lett. 319:2002;37-40
73. Ris L, Dewachter I, Reverse D, Godaux E, Van Leuven F. Capacitative calcium entry induces hippocampal long-term potentiation in the absence of presenilin-1. J Biol Chem 2003.
74. 2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91:1994;534-538
75. Leissring M.A., Parker I., LaFerla F.M. Presenilin-2 mutations modulate amplitude and kinetics of inositol 1,4,5-trisphosphate-mediated calcium signals. J. Biol. Chem. 274:1999;32535-32538
76. Leissring M.A., Paul B.A., Parker I., Cotman C.W., LaFerla F.M. Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate- mediated calcium signaling in Xenopus oocytes. J. Neurochem. 72:1999;1061-1068
77. Leissring M.A., Yamasaki T.R., Wasco W., Buxbaum J.D., Parker I., LaFerla F.M. Calsenilin reverses presenilin-mediated enhancement of calcium signaling. Proc. Natl. Acad. Sci. U.S.A. 97:2000;8590-8593
78. Leissring M.A., LaFerla F.M., Callamaras N., Parker I. Subcellular mechanisms of presenilin-mediated enhancement of calcium signaling. Neurobiol. Dis. 8:2001;469-478
79. Guo Q., Furukawa K., Sopher B.L., Pham D.G., Xie J., Robinson N., et al. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide. Neuroreport. 8:1996;379-383
80. Cedazo-Minguez A., Popescu B.O., Ankarcrona M., Nishimura T., Cowburn R.F. The presenilin 1 DeltaE9 mutation gives enhanced basal phospholipase C activity and a resultant increase in intracellular calcium concentrations. J. Biol. Chem. 277:2002;36646-36655
81. Begley J.G., Duan W., Chan S., Duff K., Mattson M.P. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J. Neurochem. 72:1999;1030-1039
82. Yoo A.S., Cheng I., Chung S., Grenfell T.Z., Lee H., Pack-Chung E., et al. Presenilin-mediated modulation of capacitative calcium entry. Neuron. 27:2000;561-572
83. Leissring M.A., Akbari Y., Fanger C.M., Cahalan M.D., Mattson M.P., LaFerla F.M. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 149:2000;793-798
84. Smith I.F., Boyle J.P., Vaughan P.F., Pearson H.A., Cowburn R.F., Peers C.S. Ca(2+) stores and capacitative Ca(2+) entry in human neuroblastoma (SH-SY5Y) cells expressing a familial Alzheimer's disease presenilin-1 mutation. Brain Res. 949:2002;105-111
85. Herms J., Schneider I., Dewachter I., Caluwaerts N., Kretzschmar H., Van Leuven F. Capacitive calcium entry is directly attenuated by mutant presenilin-1, independent of the expression of the amyloid precursor protein. J. Biol. Chem. 278:2003;2484-2489
86. Guo Q., Sopher B.L., Furukawa K., Pham D.G., Robinson N., Martin G.M., et al. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17:1997;4212-4222
87. Guo Q., Fu W., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 5:1999;101-106
88. Nakajima M., Miura M., Aosaki T., Shirasawa T. Deficiency of presenilin-1 increases calcium-dependent vulnerability of neurons to oxidative stress in vitro. J. Neurochem. 78:2001;807-814
89. Vito P., Lacana E., D'Adamio L. Interfering with apoptosis: Ca(2+)-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science. 271:1996;521-525
90. Vito P., Wolozin B., Ganjei J.K., Iwasaki K., Lacana E., D'Adamio L. Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. J. Biol. Chem. 271:1996;31025-31028
91. Vito P., Ghayur T., D'Adamio L. Generation of anti-apoptotic presenilin-2 polypeptides by alternative transcription, proteolysis, and caspase-3 cleavage. J. Biol. Chem. 272:1997;28315-28320
92. Walter J., Schindzielorz A., Grunberg J., Haass C. Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1391-1396
93. Wolozin B., Iwasaki K., Vito P., Ganjei J.K., Lacana E., Sunderland T., et al. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science. 274:1996;1710-1713
94. Kovacs D.M., Fausett H.J., Page K.J., Kim T.W., Moir R.D., Merriam D.E., et al. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2:1996;224-229
95. Keller J.N., Guo Q., Holtsberg F.W., Bruce-Keller A.J., Mattson M.P. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J. Neurosci. 18:1998;4439-4450
96. Chan S.L., Culmsee C., Haughey N., Klapper W., Mattson M.P. Presenilin-1 mutations sensitize neurons to DNA damage-induced death by a mechanism involving perturbed calcium homeostasis and activation of calpains and caspase-12. Neurobiol. Dis. 11:2002;2-19
97. Pak K., Chan S.L., Mattson M.P. Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities, and exacerbates white matter damage and memory impairment in mice. Neuromol. Med. 3:2003;53-64
98. Pak K.J., Chan S.L., Mattson M.P. Homocysteine and folate deficiency sensitize oligodendrocytes to the cell death-promoting effects of a presenilin-1 mutation and amyloid β-peptide. Neuromol. Med. 3:2003;119-128
99. Mattson M.P., Zhu H., Yu J., Kindy M.S. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis. J. Neurosci. 20:2000;1358-1364
100. Alves da Costa C., Mattson M.P., Ancolio K., Checler F. The C-terminal fragment of presenilin 2 triggers p53-mediated staurosporine-induced apoptosis, a function independent of the presenilinase-derived N-terminal counterpart. J. Biol. Chem. 278:2003;12064-12069
101. Tanii H., Ankarcrona M., Flood F., Nilsberth C., Mehta N.D., Perez-Tur J., et al. Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis. Neuroscience. 95:2000;593-601
102. Janicki S., Monteiro M.J. Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N141I). J. Cell Biol. 139:1997;485-495
103. Xu X., Shi Y.C., Gao W., Mao G., Zhao G., Agrawal S., et al. The novel presenilin-1-associated protein is a proapoptotic mitochondrial protein. J. Biol. Chem. 277:2002;48913-48922
104. Lilliehook C., Chan S., Choi E.K., Zaidi N.F., Wasco W., Mattson M.P., et al. Calsenilin enhances apoptosis by altering endoplasmic reticulum calcium signaling. Mol. Cell. Neurosci. 19:2002;552-559
105. Guo Q., Christakos S., Robinson N., Mattson M.P. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. Proc. Natl. Acad. Sci. U.S.A. 95:1998;3227-3232